|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▼
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
FINERENONE |
C03DA05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005200 |
16-02-2022 |
VALID
|
|
FLORTAUCIPIR (18F) |
V09AX07 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006064 |
22-08-2024 |
VALID
|
|
FOSDENOPTERIN |
A16AX19 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005378 |
15-09-2022 |
VALID
|
|
FRUQUINTINIB |
L01EK04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005979 |
20-06-2024 |
VALID
|
|
FUTIBATINIB |
L01EN04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005627 |
04-07-2023 |
VALID
|
|
GADOPICLENOL |
V08CA12 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006172 |
07-12-2023 |
VALID
|
|
GALLIUM (68GA) GOZETOTIDE |
V09IX14 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005488 |
09-12-2022 |
VALID
|
|
GLOFITAMAB |
L01FX28 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005751 |
07-07-2023 |
VALID
|
|
INEBILIZUMAB |
L04AG10 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005818 |
25-04-2022 |
VALID
|
|
INFLUENZA VACCINE (LIVE ATTENUATED, NASAL) |
J07BB03 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006514 |
03-06-2024 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES) |
J07BB02 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006051 |
19-04-2024 |
VALID
|
|
INSULIN ICODEC |
A10AE07 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005978 |
17-05-2024 |
VALID
|
|
IPTACOPAN |
L04AJ08 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005764 |
17-05-2024 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|
|
LASMIDITAN |
N02CC08 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005332 |
17-08-2022 |
VALID
|
|
LENACAPAVIR |
J05AX31 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005638 |
17-08-2022 |
VALID
|
|
LINZAGOLIX |
H01CC04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005442 |
14-06-2022 |
VALID
|
|
LONAFARNIB |
A16AX20 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005271 |
18-07-2022 |
VALID
|
|
LONAPEGSOMATROPIN |
H01AC09 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005367 |
11-01-2022 |
VALID
|
|
LONCASTUXIMAB TESIRINE |
L01FX22 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005685 |
20-12-2022 |
VALID
|
|
LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN |
V10XX05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005483 |
09-12-2022 |
VALID
|
|
MARALIXIBAT CHLORIDE |
A05AX04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005857 |
09-12-2022 |
VALID
|
|
MELPHALAN FLUFENAMIDE |
L01AA10 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005681 |
17-08-2022 |
VALID
|
|
MIRIKIZUMAB |
L04AC24 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005122 |
26-05-2023 |
VALID
|
|
MITAPIVAT |
B06AX04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005540 |
09-11-2022 |
VALID
|
|
MOMELOTINIB |
L01EJ04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005768 |
25-01-2024 |
VALID
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
NIVOLUMAB AND RELATLIMAB |
L01FY02 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005481 |
15-09-2022 |
VALID
|
|
OLIPUDASE ALFA |
A16AB25 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004850 |
24-06-2022 |
VALID
|
|
PALOPEGTERIPARATIDE |
H05AA05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005934 |
17-11-2023 |
VALID
|
|
PEGCETACOPLAN |
L04AJ03 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005553 |
13-12-2021 |
VALID
|
|
PEGUNIGALSIDASE ALFA |
A16AB20 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005618 |
04-05-2023 |
VALID
|
|
PEGZILARGINASE |
A16AB24 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005484 |
15-12-2023 |
VALID
|
|
PIFLUFOLASTAT (18F) |
V09IX16 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005520 |
24-07-2023 |
VALID
|
|
PRALSETINIB |
L01EX23 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005413 |
18-11-2021 |
VALID
|
|
QUIZARTINIB |
L01EX11 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005910 |
06-11-2023 |
VALID
|
|
REGDANVIMAB |
J06BD06 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005854 |
12-11-2021 |
VALID
|
|
RELUGOLIX |
L02BX04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005353 |
29-04-2022 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
RETIFANLIMAB |
L01FF10 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006194 |
19-04-2024 |
VALID
|
|
RIMEGEPANT |
N02CD06 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005725 |
25-04-2022 |
VALID
|
|
RITLECITINIB |
L04AF08 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006025 |
15-09-2023 |
VALID
|
|
ROZANOLIXIZUMAB |
L04AG16 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005824 |
05-01-2024 |
VALID
|
|
RUXOLITINIB |
D11AH09 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005843 |
19-04-2023 |
VALID
|
|
SACITUZUMAB GOVITECAN |
L01FX17 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005182 |
22-11-2021 |
VALID
|
|
SINGLE-STRANDED 5' CAPPED MRNA ENCODING RESPIRATORY SYNCYTIAL VIRUS GLYCOPROTEIN F STABILIZED |
J07BX05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006278 |
22-08-2024 |
VALID
|
|
SOMATROGON |
H01AC08 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005633 |
14-02-2022 |
VALID
|
|
SOTATERCEPT |
C02KC06 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005647 |
22-08-2024 |
VALID
|
|
SOTROVIMAB |
J06BD05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005676 |
17-12-2021 |
VALID
|